Skip to content
drillr.ai
Sign up

603392.SH

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

SSE · Healthcare · Biotechnology · CN

CNY 28.09
−8.17%
Ask drillr

  • Sep 7, 2026, 10:40 UTC

    Wantai Biological announced plans to terminate its 2021 private placement project for a 20-valent pneumococcal polysaccharide conjugate vaccine and redirect the remaining raised funds of 455 million yuan to a new high-valent pneumococcal polysaccharide conjugate vaccine project with a total investment of 2.437 billion yuan.

    Source:

  • Aug 19, 2026, 08:28 UTC

    Wantai Biological announced its first-half 2026 results: revenue of 1.048 billion yuan, up 24.29% year-on-year, and a net loss attributable to shareholders of 128 million yuan, compared with a loss of 144 million yuan in the same period last year.

    Source:

  • Jul 3, 2026, 07:37 UTC

    Wantai Biological's director and general manager JIANG ZHIMING resigned on July 2, 2026, and chairman Qiu Zixin will temporarily assume the general manager duties.

    Source: